MedTrace Logo

AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation

NCT01460108 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2011-10-27

No results posted yet for this study

Summary

The purpose of this study is to characterize the safety and efficacy of the AeriSeal System in patients with advanced upper lobe predominant emphysema and significant collateral ventilation as determined by the Chartis System.

Conditions

  • Pulmonary Emphysema
  • COPD
  • Lung Diseases

Interventions

DEVICE

AeriSeal System

20 mL

Sponsors & Collaborators

  • LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology

    lead NETWORK

Principal Investigators

  • Arschang Valipour, MD, FCCP · Ludwig-Boltzmann-Institut für COPD und Pneumologische Epidemiologie

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2012-12-31
Completion
2013-06-30

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01460108 on ClinicalTrials.gov